Dexcom (DXCM) Current Leases (2019 - 2026)

Dexcom (DXCM) has 8 years of Current Leases data on file, last reported at $20.5 million in Q1 2026.

• Quarterly Current Leases fell 9.29% year-over-year to $20.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.5 million (down 9.29% YoY) and the FY2025 annual result came in at $21.6 million, down 4.0% from the prior year.
• Current Leases fell to $20.5 million in Q1 2026 per DXCM's latest filing, from $21.6 million in the prior quarter.
• Across five years, Current Leases topped out at $23.6 million in Q3 2025 and bottomed at $20.5 million in Q4 2022.
• The 5-year median for Current Leases is $21.6 million (2024), against an average of $21.7 million.
• The widest annual swing landed in 2022, when Current Leases gained 14.84%; it then declined 9.29% in 2026.
• Tracing DXCM's Current Leases over 5 years: stood at $20.5 million in 2022, then rose by 2.93% to $21.1 million in 2023, then rose by 6.64% to $22.5 million in 2024, then slipped by 4.0% to $21.6 million in 2025, then dropped by 5.09% to $20.5 million in 2026.
• Per Business Quant, the three latest DXCM Current Leases figures stand at $20.5 million (Q1 2026), $21.6 million (Q4 2025), and $23.6 million (Q3 2025).

Peer Comparison